Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ELVN compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
ELVN
Enliven Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
JBIO
Jade Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ELVN
Enliven Therapeutics, Inc.
vs
JBIO
Jade Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
ELVN
Enliven Therapeutics, Inc.
Change
44.61
· pre 44.61
· delayed
Mkt cap
$3.3B
JBIO
Jade Biosciences, Inc.
Change
14.07
· pre 14.44
Pre-market
Nov 3 '26
Mkt cap
$885.9M
vs
Compare
Pre-market
Nov 3 '26
ELVN
Enliven Therapeutics, Inc.
vs
JBIO
Jade Biosciences, Inc.
44.61
pre 44.61
delayed
Price
14.07
pre 14.44
$3.3B
Mkt cap
$885.9M
Change
Change
ELVN
44.61
vs
JBIO
14.07
Pre-market
Nov 3 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ELVN, solid
JBIO, dashed